BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Diagnosis
252 results:

  • 1. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
    Li L; Zhang M; Zhang TT; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
    [No Abstract]    [Full Text] [Related]  

  • 2. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
    Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
    Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acute mast cell leukemia without kit D816V mutation and lack of CD2 and CD25-a case report of rare entity.
    Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
    J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Metastatic Undifferentiated Melanoma Mimicking a Primary bone Tumor: A Potential Diagnostic Pitfall.
    Wills A; Dibbern M; Frierson HF; Raghavan SS
    Am J Dermatopathol; 2024 Mar; 46(3):170-172. PubMed ID: 38170737
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH).
    Mounika N; Yadav A; Kamboj P; Banerjee SK; Deka UJ; Kaur S; Adela R
    PLoS One; 2023; 18(12):e0295839. PubMed ID: 38127951
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology.
    Miettinen M; Abdullaev Z; Turakulov R; Quezado M; Luiña Contreras A; Curcio CA; Rys J; Chlopek M; Lasota J; Aldape KD
    Am J Surg Pathol; 2024 Jan; 48(1):112-122. PubMed ID: 37921028
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Induction chemotherapy response of HPV-related multiphenotypic sinonasal carcinoma: First-ever reported therapeutic outcome and a brief literature review.
    Vieira GS; Perin MY; Figueiredo-Maciel T; Risuenho AJG; Carvalho de Oliveira V; Macedo LT; Altemani JMC; Chone CT; Egal ESA; Lima CSP; Altemani A; Mariano FV
    Oral Oncol; 2023 Nov; 146():106555. PubMed ID: 37639765
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.
    Wu Y; Zhang X; Ma X; Suo X; Li R
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Systemic Mastocytosis with Associated Hematological Neoplasms. Diagnostic features and unique response pattern to tyrosine kinase inhibitors and allo-bone marrow transplantation therapy.
    Hernández Alconchel I; González de Villambrosía S; Insunza Gaminde A; Montes Moreno S
    Rev Esp Patol; 2023; 56(3):180-185. PubMed ID: 37419556
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
    Jain T; Ware AD; Dalton WB; Pasca S; Tsai HL; Gocke CD; Gondek LP; Xian RR; Borowitz MJ; Levis MJ
    Leuk Res; 2023 Aug; 131():107345. PubMed ID: 37354804
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The FBXO32/ATR/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
    Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.
    Tang H; Panse G; Braddock D; Perincheri S; Xu ML; McNiff JM
    J Cutan Pathol; 2023 Jul; 50(7):595-600. PubMed ID: 37082914
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
    Nong L; Wang W; Liang L; Li D; Li X; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Utility of Retrospective Molecular Analysis in Diagnostically Challenging Mesenchymal Neoplasms.
    Mindiola Romero AE; Tafe LJ; Green DC; Deharvengt SJ; Winnick KN; Tsongalis GJ; Baker ML; Linos K; Levy JJ; Kerr DA
    Int J Surg Pathol; 2023 Dec; 31(8):1473-1484. PubMed ID: 36911994
    [No Abstract]    [Full Text] [Related]  

  • 16. Systemic mastocytosis mimicking blastic plasmacytoid dendritic cell neoplasm: a case report.
    Zhang X; Han J; Zhu N; Ji Y; Hou Y
    Diagn Pathol; 2023 Feb; 18(1):17. PubMed ID: 36759849
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
    Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The prognostic role of C-kit, TET1 and TET2 gene expression in Acute Myeloid Leukemia.
    Nabil R; Hassan NM; Abdellateif MS; Gawdat RM; Elshazly SS
    Mol Biol Rep; 2023 Jan; 50(1):641-653. PubMed ID: 36371552
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.
    Kennedy VE; Perkins C; Reiter A; Jawhar M; Lübke J; Kluin-Nelemans HC; Shomali W; Langford C; Abuel J; Hermine O; Niedoszytko M; Gorska A; Mital A; Bonadonna P; Zanotti R; Tanasi I; Mattsson M; Hagglund H; Triggiani M; Yavuz AS; Panse J; Christen D; Heizmann M; Shoumariyeh K; Müller S; Elena C; Malcovati L; Fiorelli N; Wortmann F; Vucinic V; Brockow K; Fokoloros C; Papageorgiou SG; Breynaert C; Bullens D; Doubek M; Ilerhaus A; Angelova-Fischer I; Solomianyi O; Várkonyi J; Sabato V; Rüfer A; Schug TD; Hermans MAW; Fortina AB; Caroppo F; Bumbea H; Gulen T; Hartmann K; Elberink HO; Schwaab J; Arock M; Valent P; Sperr WR; Gotlib J
    Blood Adv; 2023 May; 7(9):1713-1724. PubMed ID: 36094848
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with
    Hwang SM; Kim BJ; Lee JS; Seong MW; Seo SH; Paik JH; Kim SA; Lee JY; Lee JO; Chang YH; Bang SM
    Ann Lab Med; 2022 Nov; 42(6):678-682. PubMed ID: 35765876
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.